Investments
12Portfolio Exits
5Funds
1About Quatris Fund
Quatris combines the talent and private capital of its four principals with the financial assets and support of St. Paul Venture Capital, which has committed $15 million to Quatris. Quatris Principals Steven Goldstein, Erwin Kelen, John Rollwagen and Gary Smaby all have extensive experience in starting, building and managing companies -- from start-ups to major high technology enterprises. With a mission to build great companies, Quatris is committed to identifying and nurturing seed stage ventures in Minnesota and the Upper Midwest.
Want to inform investors similar to Quatris Fund about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Quatris Fund News
Sep 1, 2016
Verify here. The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com. All rights reserved. All other trademarks recognized. Copyright © 1997-2016 BioPortfolio Limited. Site developed by Alacrify Ltd .
Quatris Fund Investments
12 Investments
Quatris Fund has made 12 investments. Their latest investment was in Rebiotix as part of their Series B on August 8, 2014.
Quatris Fund Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/4/2014 | Series B | Rebiotix | $25M | No | 2 | |
11/4/2011 | Series A | Rebiotix | $5M | Yes | Michael Berman, Quatris Fund, and Undisclosed Angel Investors | |
3/13/2006 | Series D | Cassatt Corporation | $15M | Yes | ||
4/21/2004 | Seed | |||||
1/16/2004 | Series B |
Date | 8/4/2014 | 11/4/2011 | 3/13/2006 | 4/21/2004 | 1/16/2004 |
|---|---|---|---|---|---|
Round | Series B | Series A | Series D | Seed | Series B |
Company | Rebiotix | Rebiotix | Cassatt Corporation | ||
Amount | $25M | $5M | $15M | ||
New? | No | Yes | Yes | ||
Co-Investors | Michael Berman, Quatris Fund, and Undisclosed Angel Investors | ||||
Sources | 2 |
Quatris Fund Portfolio Exits
5 Portfolio Exits
Quatris Fund has 5 portfolio exits. Their latest portfolio exit was Rebiotix on April 05, 2018.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/5/2018 | Acquired | 3 | |||
Date | 4/5/2018 | ||||
|---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 3 |
Quatris Fund Fund History
1 Fund History
Quatris Fund has 1 fund, including Quatris Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
7/1/2000 | Quatris Fund | Early-Stage Venture Capital | Closed | $13M | 1 |
Closing Date | 7/1/2000 |
|---|---|
Fund | Quatris Fund |
Fund Type | Early-Stage Venture Capital |
Status | Closed |
Amount | $13M |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.